|
|
|
|
|
1
|
Biotechnology Sector |
Nov 2009 |
$129.00 |
|
The US biotechnology industry includes about 1,500 companies with combined annual revenue of about $70 billion. Major companies include Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), Genzyme, Life Technologies, and Monsanto. Because many drugs
more...
Published by: First Research, Inc.
| Search inside this report |
|
|
2
|
Dealmaking and Industry Outlook: Neurological Disease |
Nov 2009 |
$2,250.00 |
|
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying
causes of these diseases are far from certain; as a result, therapeutic strategies in effect today may
more...
Published by: Decision Resources
|
|
|
3
|
Protein Kinase Therapeutics in Oncology - Where to Commercialize? |
Oct 2009 |
$3,500.00 |
|
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of
more...
Published by: BioSeeker Group AB
|
|
|
4
|
Plunkett's Health Care Technologies Overview 2010 (Summary) |
Oct 2009 |
$199.99 |
|
This summary contains the complete technologies section excerpted from the highly-acclaimed Plunkett's Health Care Industry Almanac. This report will be your ready-reference guide to new and developing health care technologies. Technology topics range from stem
more...
Published by: Plunkett Research, Ltd.
| Search inside this report |
|
|
5
|
The Human Genome Sequencing Center at Baylor College of Medicine Relies on Quantum's StorNext Software for Data Management |
Oct 2009 |
$3,500.00 |
|
This IDC Buyer Case Study examines how one research institution utilizes Quantum's StorNext data management software to support its growing storage
more...
Published by: IDC
| Search inside this report |
|
|
6
|
Genetic Engineering |
Oct 2009 |
$950.00 |
|
The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers a bird’s eye view of the industry, highlights latest developments, and discusses demand
more...
Published by: Global Industry Analysts
|
|
|
7
|
Three Alternative Scenarios Of The Future In Vitro Diagnostics Market 2009-2018 |
Oct 2009 |
$11,800.00 |
|
This report is an invaluable strategic planning resources for corporate, marketing and R&D executives. This report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include to
more...
Published by: Venture Planning Group
|
|
|
8
|
Preventive Healthcare Technologies, Products and Markets |
Oct 2009 |
$4,850.00 |
|
THIS REPORT:
Forecasts for the U.S. market in products and services, providing data for 2008 and estimates for 2009, and projections for the market and compound annual growth rates (CAGRs) from 2009 to 2014,
more...
Published by: BCC Research
| Search inside this report |
|
|
9
|
Transfection Life Science Dashboard™ Series 2 |
Oct 2009 |
$3,850.00 |
|
The ability to transfect DNA into mammalian cells and cell lines is a critical step in the analysis of gene expression, protein structure and function and molecular interactions within the cell. The Transfection Dashboard
more...
Published by: Percepta Associates, Inc.
| Search inside this report |
|
|
10
|
Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook |
Oct 2009 |
$3,835.00 |
|
Microarrays and biochips are small devices capable of detecting and measuring large numbers of biomarkers simultaneously. Although microarrays have been in research use for over a decade it is only recently that they have moved
more...
Published by: Business Insights
| Search inside this report |
|
|
11
|
Genealogy Products and Services |
Oct 2009 |
$950.00 |
|
The global outlook series on Genealogy Products and Services provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird’s eye view of the industry; highlights latest
more...
Published by: Global Industry Analysts
|
|
|
12
|
Genetic Diseases and Dysmorphic Syndromes Gaucher's Disease Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Gaucher's Disease Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of gaucher's disease drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |
|
|
13
|
Genetic Diseases and Dysmorphic Syndromes Turner's Syndrome Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Turner's Syndrome Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of turner's syndrome drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |
|
|
14
|
Genetic Diseases and Dysmorphic Syndromes Wilson Disease Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Wilson Disease Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of wilson disease drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |
|
|
15
|
Biomarkers- Advanced Technologies and Global Market (2009-2014) |
Sep 2009 |
$4,650.00 |
|
Report Description
The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and
more...
Published by: MarketsandMarkets
| Search inside this report |
|
|
16
|
U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions |
Sep 2009 |
$1,800.00 |
|
DNA-based diagnostics are established in laboratory medicine with many of the top tests run for infectious disease. The U.S. market for DNA-based infectious disease tests is today a $1.1 billion industry. Nucleic acid testing (NAT)
more...
Published by: Fuji-Keizai USA, Inc.
|
|
|
17
|
Diabetes R & D Pipeline: Cell and Stem Cell Therapies |
Sep 2009 |
$650.00 |
|
This report addresses the recent advances in research and development of pancreatic islet cell
and stem cell therapies for the treatment diabetes, primarily of type 1 diabetes. The
report features 10 cell and stem cell
more...
Published by: BioPolaris
| Search inside this report |
|
|
18
|
Uncovering Biomarker and Diagnostic Opportunities in Immune and Inflammatory Diseases |
Aug 2009 |
$2,250.00 |
|
Introduction
Despite the robust drug market for immune and infl ammatory diseases and their high prevalence, diagnostics associated
with these diseases do not constitute a large marketplace. Although researchers are working to discover
biomarkers, associate
more...
Published by: Decision Resources
|
|
|
19
|
Neurological Disease: Early-Stage R&D and Dealmaking |
Aug 2009 |
$2,250.00 |
|
Introduction
How can early-stage R&D efforts be positioned to tap the remaining opportunity in the neurology
drug market? Although brimming with potential, neurology drug development is also rife with unique
challenges that many companies and
more...
Published by: Decision Resources
|
|
|
20
|
Plunkett's Biotech & Genetics Industry Almanac 2010 |
Aug 2009 |
$299.99 |
|
Plunkett's Biotech & Genetics Industry Almanac is a complete reference guide to the business side of biotechnology, genetics, proteomics and related services. This new book contains complete profiles of the leading biotech companies, in-depth chapters
more...
Published by: Plunkett Research, Ltd.
| Search inside this report |
|
|
21
|
Plunkett's Biotech & Genetics Industry Trends & Statistics 2010 (Summary) |
Aug 2009 |
$199.99 |
|
This carefully-researched report will be your ready-reference guide to the Biotechnology and Genetics Industry. Excerpted from Plunkett's Biotech and Genetics Industry Almanac, this summary includes our analysis of the major trends, from the convergence of
more...
Published by: Plunkett Research, Ltd.
| Search inside this report |
|
|
22
|
DNA Sequencing Equipment and Services Markets, 2nd Edition |
Aug 2009 |
$3,800.00 |
|
Since the last edition of Kalorama Information's DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the
more...
Published by: Kalorama Information
| Search inside this report |
|
|
23
|
Bioarrays for Life Science Research, Diagnostics and Drug R&D |
Aug 2009 |
$2,495.00 |
|
This research report is about the worldwide bioarray tools, technologies and services market. Bioarrays are also known as DNA microarrays, protein arrays, or biochips. These key mainstream life science research products and services involve technologies
more...
Published by: Takeda Pacific
|
|
|
24
|
Expanding Applications of Personalized Medicine: Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach |
Aug 2009 |
$3,835.00 |
|
Introduction
Against a background of increasing commercial pressures the need to find new markets and exploit them has never been greater. At the same time changes in prevailing healthcare thinking with respect to the
more...
Published by: Business Insights
| Search inside this report |
|
|
25
|
The World Market for Biosimilars and the Potential for US Follow-on Biologics |
Aug 2009 |
$3,700.00 |
|
Biosimilars, or generic biologic drugs, are marketed around the world but still restricted in the U.S. This may soon change, and Kalorama Information has released this timely study of the market in Europe and
more...
Published by: Kalorama Information
| Search inside this report |
|
|
|
|
|
0 items
